MA09.06 Viagenpumatucel-L Bolsters Response to Nivolumab Therapy in Advanced Lung Adenocarcinoma: Preliminary Data from the DURGA Trial
Morgensztern D, Harb W, Schalper K, Price M, Early B, Schreiber T. MA09.06 Viagenpumatucel-L Bolsters Response to Nivolumab Therapy in Advanced Lung Adenocarcinoma: Preliminary Data from the DURGA Trial. Journal Of Thoracic Oncology 2017, 12: s394-s395. DOI: 10.1016/j.jtho.2016.11.447.Peer-Reviewed Original Research